Corporate News – Market Overview
Taysha Gene Therapies (TSHA)
- Price movement: TSHA shares increased by 0.24 % during the 24‑hour period ending at 03:56 AM Central Europe on Friday, 23 July 2026.
- Current trading price: Approximately USD 4.00 per share on major exchanges.
- Shares outstanding: 326 million.
- Market capitalization: USD 1.30 billion.
- Trading volume: USD 14.50 million of TSHA shares were exchanged in the last 24 hours.
- Month‑end performance: The share price has fallen 20.16 % since the previous month‑end.
- Moving averages: The simple moving average over the last 200 trading days is USD 5.36.
- 52‑week range: The highest price recorded was USD 7.30 on 6 May 2026; the lowest price was USD 3.46 on 14 October 2026.
Related Stock Performance (Last 24 Hours)
| Ticker | Direction | % Change | Current Price (USD) | Market Cap (USD) | P/E Ratio |
|---|---|---|---|---|---|
| HUBG | Down | -0.08 % | 26.47 | 1.60 billion | 17.27 |
| AZTA | Up | 2.88 % | 36.01 | 1.60 billion | – |
| SECZ | Down | -1.61 % | 7.97 | 1.60 billion | – |
| OCFC | Up | 0.06 % | 16.62 | 1.60 billion | 20.18 |
| CTS | Up | 1.64 % | 53.53 | 1.60 billion | 23.15 |
Company Profile
Taysha Gene Therapies, Inc. is a pharmaceutical firm headquartered in Dallas, United States, that focuses on developing therapies for monogenic diseases of the central nervous system. The company operates globally and is listed on the Nasdaq stock exchange. Its official website is accessible at www.tayshagtx.com .
